ACI HealthCare Limited (AHL), a private limited company, incorporated in the year 2013 under the Companies Act 1994. The principal activities of ACI HealthCare Limited are to manufacture and market pharmaceutical products for regulated markets, especially for USA and Local markets. ACI HealthCare Limited own approx. 12 acres of land in Sonargaon, Bangladesh site. Currently, a six storied state-of-the-art manufacturing facility for non-potent products has been completed for AHL and is in operational having current capacity and capability for multiproduct, multiuse non potent oral solids (Tablets & Capsules). The site has been approved by different regulatory bodies including US FDA. ACI HealthCare Limited have expanded its own Sales, Marketing and Distribution operations within country as well as in USA through AHL’s subsidiary company ACI Healthcare USA, Inc. for Sales, Marketing and Distribution of own products and products of other companies. US FDA has already approved 12 ANDAs (24 SKUs) including Gabapentin Tablets, Gabapentin Capsules, Azithromycin Tablets, Levetiracetam Tablets, Donepezil Tablets etc.